Immunogenicity and safety of an E. coli-produced human papillomavirus vaccine: A phase 2 controlled trial

Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial
Source: Read Full Article